HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis.

AbstractOBJECTIVE:
The purpose of this study was to clarify the role of glycoxidation and lipid peroxidation of low-density lipoprotein (LDL) in atherogenesis.
METHODS AND RESULTS:
We examined the formation of N(epsilon)-(carboxymethyl) lysine (CML), a glycoxidation product, and malondialdehyde (MDA), a lipid peroxidation product, in vitro and their co-localization in human atherosclerotic lesions. Immunochemical analysis revealed that CML was formed in a time-dependent manner by human LDL incubated with copper ions and glucose, i.e. an in vitro model of glycoxidation of LDL. When LDL was exposed to copper ions alone, a small amount of CML was formed, however this was significantly less in oxidized LDL than glycoxidative LDL. In contrast, MDA formation was observed in both oxidation and glycoxidation of LDL, but not in glycation of LDL. Hexitol-lysine (HL), an Amadori product, was formed by both glycation and glycoxidation of LDL, but not by oxidation of LDL. Immunohistochemical analysis showed that CML and MDA accumulated mainly in macrophage/foam cells, while pyrraline, a non-oxidative product of glycation, and apolipoprotein B were localized in the extracellular matrix in atherosclerotic lesions. Atheromas were positive for CML and MDA, but negative for pyrraline. Macrophage/foam cells in atherosclerotic lesions exhibited co-localization of macrophage scavenger receptor-A with CML and MDA, but not with pyrraline.
CONCLUSION:
Our results suggest that glycoxidation and lipid peroxidation of LDL synergistically promote the development of atherosclerotic lesions through interaction with macrophage scavenger receptor-A.
AuthorsN Sakata, N Uesugi, S Takebayashi, R Nagai, T Jono, S Horiuchi, M Takeya, H Itabe, T Takano, T Myint, N Taniguchi
JournalCardiovascular research (Cardiovasc Res) Vol. 49 Issue 2 Pg. 466-75 (Feb 01 2001) ISSN: 0008-6363 [Print] England
PMID11164857 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chelating Agents
  • Enzyme Inhibitors
  • Guanidines
  • Lipoproteins, LDL
  • Receptors, Immunologic
  • Receptors, Scavenger
  • Malondialdehyde
  • N(6)-carboxymethyllysine
  • Copper
  • Pentetic Acid
  • Edetic Acid
  • Glucose
  • Lysine
  • pimagedine
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Arteriosclerosis (metabolism)
  • Chelating Agents (pharmacology)
  • Copper (metabolism)
  • Edetic Acid (pharmacology)
  • Enzyme Inhibitors (pharmacology)
  • Enzyme-Linked Immunosorbent Assay (methods)
  • Female
  • Glucose (metabolism)
  • Guanidines (pharmacology)
  • Humans
  • Immunohistochemistry
  • Lipid Peroxidation
  • Lipoproteins, LDL (metabolism)
  • Lysine (analogs & derivatives, analysis, metabolism)
  • Male
  • Malondialdehyde (analysis, metabolism)
  • Middle Aged
  • Pentetic Acid (pharmacology)
  • Receptors, Immunologic (analysis)
  • Receptors, Scavenger

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: